These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 30835584)

  • 1. Circulating HO-1 levels are not associated with plasma sFLT-1 and GT
    Sandrim V; Coeli-Lacchini FB; Tanus-Santos JE; Lacchini R; Cavalli RC
    Hypertens Pregnancy; 2019 May; 38(2):73-77. PubMed ID: 30835584
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum heme oxygenase 1 (HO-1), soluble FMS like tyrosine kinase (sFlt-1) level, and neonatal outcome in early onset, late onset preeclampsia, and normal pregnancy.
    Aldika Akbar MI; Herdiyantini M; Aryananda RA; CIninta N; Wardhana MP; Gumilar KE; Wicaksono B; Ernawati ; Sulistyono A; Aditiawarman ; Joewono HT; Nadir Abdullah ; Dekker G; Dachlan EG; Dikman Angsar M
    Hypertens Pregnancy; 2018 Nov; 37(4):175-181. PubMed ID: 30277426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microsatellite polymorphism in the heme oxygenase-1 promoter is associated with nonsevere and late-onset preeclampsia.
    Kaartokallio T; Klemetti MM; Timonen A; Uotila J; Heinonen S; Kajantie E; Kere J; Kivinen K; Pouta A; Lakkisto P; Laivuori H
    Hypertension; 2014 Jul; 64(1):172-7. PubMed ID: 24799610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic potential of statins and the induction of heme oxygenase-1 in preeclampsia.
    Ramma W; Ahmed A
    J Reprod Immunol; 2014 Mar; 101-102(100):153-160. PubMed ID: 24503248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fetal Microsatellite in the Heme Oxygenase 1 Promoter Is Associated With Severe and Early-Onset Preeclampsia.
    Kaartokallio T; Utge S; Klemetti MM; Paananen J; Pulkki K; Romppanen J; Tikkanen I; Heinonen S; Kajantie E; Kere J; Kivinen K; Pouta A; Lakkisto P; Laivuori H
    Hypertension; 2018 Jan; 71(1):95-102. PubMed ID: 29203625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sofalcone upregulates the nuclear factor (erythroid-derived 2)-like 2/heme oxygenase-1 pathway, reduces soluble fms-like tyrosine kinase-1, and quenches endothelial dysfunction: potential therapeutic for preeclampsia.
    Onda K; Tong S; Nakahara A; Kondo M; Monchusho H; Hirano T; Kaitu'u-Lino T; Beard S; Binder N; Tuohey L; Brownfoot F; Hannan NJ
    Hypertension; 2015 Apr; 65(4):855-62. PubMed ID: 25667213
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heme Oxygenase-1 Is Not Decreased in Preeclamptic Placenta and Does Not Negatively Regulate Placental Soluble fms-Like Tyrosine Kinase-1 or Soluble Endoglin Secretion.
    Tong S; Kaitu'u-Lino TJ; Onda K; Beard S; Hastie R; Binder NK; Cluver C; Tuohey L; Whitehead C; Brownfoot F; De Silva M; Hannan NJ
    Hypertension; 2015 Nov; 66(5):1073-81. PubMed ID: 26324507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women.
    Rajakumar A; Michael HM; Rajakumar PA; Shibata E; Hubel CA; Karumanchi SA; Thadhani R; Wolf M; Harger G; Markovic N
    Placenta; 2005 Aug; 26(7):563-73. PubMed ID: 15993706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating angiogenic factors and their association with birth outcomes in preeclampsia.
    Kulkarni AV; Mehendale SS; Yadav HR; Kilari AS; Taralekar VS; Joshi SR
    Hypertens Res; 2010 Jun; 33(6):561-7. PubMed ID: 20224572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Markers of obesity and growth in preeclamptic and normotensive pregnant women.
    Kharb S; Bala J; Nanda S
    J Obstet Gynaecol; 2017 Jul; 37(5):610-615. PubMed ID: 28467127
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maternal plasma concentrations of the placental specific sFLT-1 variant, sFLT-1 e15a, in fetal growth restriction and preeclampsia.
    Palmer KR; Kaitu'u-Lino TJ; Cannon P; Tuohey L; De Silva MS; Varas-Godoy M; Acuña S; Galaz J; Tong S; Illanes SE
    J Matern Fetal Neonatal Med; 2017 Mar; 30(6):635-639. PubMed ID: 27124553
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels of increased miR-195-5p correlates with the sFLT-1 levels in preeclampsia.
    Sandrim VC; Eleuterio N; Pilan E; Tanus-Santos JE; Fernandes K; Cavalli R
    Hypertens Pregnancy; 2016 May; 35(2):150-8. PubMed ID: 26910493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive value of the sFlt-1 and PlGF in women at risk for preeclampsia in the south of Vietnam.
    Nguyen TH; Bui TC; Vo TM; Tran QM; Luu LT; Nguyen TD
    Pregnancy Hypertens; 2018 Oct; 14():37-42. PubMed ID: 30527116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated serum sFlt-1/Ang-2 ratio in women with preeclampsia.
    Hirokoshi K; Maeshima Y; Kobayashi K; Matsuura E; Sugiyama H; Yamasaki Y; Masuyama H; Hiramatsu Y; Makino H
    Nephron Clin Pract; 2007; 106(1):c43-50. PubMed ID: 17409768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insights into the etiology of preeclampsia: identification of key elusive factors for the vascular complications.
    Ahmed A
    Thromb Res; 2011 Feb; 127 Suppl 3():S72-5. PubMed ID: 21262447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a new and automated electrochemiluminescence immunoassay for plasma sFlt-1 and PlGF levels in women with preeclampsia.
    Ohkuchi A; Hirashima C; Suzuki H; Takahashi K; Yoshida M; Matsubara S; Suzuki M
    Hypertens Res; 2010 May; 33(5):422-7. PubMed ID: 20150910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MZe786, a hydrogen sulfide-releasing aspirin prevents preeclampsia in heme oxygenase-1 haplodeficient pregnancy under high soluble flt-1 environment.
    Rezai H; Ahmad S; Alzahrani FA; Sanchez-Aranguren L; Dias IH; Agrawal S; Sparatore A; Wang K; Ahmed A
    Redox Biol; 2021 Jan; 38():101768. PubMed ID: 33137710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expression of serum sEGFR, sFlt-1, sEndoglin and PLGF in preeclampsia.
    Cui L; Shu C; Liu Z; Tong W; Cui M; Wei C; Tang JJ; Liu X; Hu J; Jiang J; He J; Zhang DY; Ye F; Li Y
    Pregnancy Hypertens; 2018 Jul; 13():127-132. PubMed ID: 30177039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circulating angiogenic factors and the risk of preeclampsia.
    Levine RJ; Maynard SE; Qian C; Lim KH; England LJ; Yu KF; Schisterman EF; Thadhani R; Sachs BP; Epstein FH; Sibai BM; Sukhatme VP; Karumanchi SA
    N Engl J Med; 2004 Feb; 350(7):672-83. PubMed ID: 14764923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Arginase controls soluble vascular endothelial growth factor receptor 1 (sFlt1) to maintain pregnancy homeostasis.
    Tanaka H; Kumasawa K; Kakigano A; Mimura K; Endo M; Tomimatsu T; Kimura T
    Biochem Biophys Res Commun; 2018 May; 499(2):150-155. PubMed ID: 29548823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.